The other day a friend sent me a research report suggesting to buy a particular stock that had “excellent growth potential.” Best of all, the stock was trading at just 15 times earnings. So for my friend, this seemed like…
Learn moreThe world has changed a lot since I started in financial services. I got my Series-6 to sell variable insurance products and mutual funds in 1984. Although I never sold one, I got a Series-22 just in case I ran…
Learn moreThe Dow Jones slumped more than 160 points in premarket hours as investors continued to rotate from growth stocks into more cyclical stocks. Recent announcements by Pfizer (PFE) and Moderna (MRNA) on their new vaccines has given investors optimism that…
Learn moreThe S&P futures are up 12 points in premarket hours as investors attempt to bounce back from an ugly selloff on Monday. Shares plunged yesterday on reports of rising U.S. COVID cases, uncertainty about Congressional stimulus before the election, and…
Learn more